Clinical Trials in Phoenix

Showing 6201-6220 of 16,646 trials

Stories for Change: Early Detection Can Save Lives

NCT05956353

The purpose of this study is to evaluate the Stories for Change (S4C) Cancer Prevention digital storytelling intervention for acceptability and socio-behavioral constructs to increase cancer screening among Hispanic or Latino individuals.

Prevention

Mayo Clinic51 participantsStarted Aug 2023

Phoenix, Arizona, United States • Minneapolis, Minnesota, United States • Rochester, Minnesota, United States

COMPLETEDPhase 3< 1 mile

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

NCT04279314

To investigate the safety and tolerability of long-term treatment with oral trofinetide in girls and women with Rett syndrome

Rett Syndrome

ACADIA Pharmaceuticals Inc.154 participantsStarted Jan 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • La Jolla, California, United States +18 more locations

Stories for Change: Early Detection Can Save Lives

Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome

Find Trials by Condition in Phoenix

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar Pain

A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Study Using Negative Pressure to Reduce Apnea

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

Safety and Effectiveness Study of the Zenflow Spring System

Expanded Access Program of Surufatinib

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease

Treatment of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study)

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIIB107 in Healthy Adult Participants

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Financial Incentives, Randomization With Stepped Treatment Trial

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection